Skip to main content
. Author manuscript; available in PMC: 2024 May 8.
Published in final edited form as: Eur J Endocrinol. 2023 Jul 20;189(1):123–131. doi: 10.1093/ejendo/lvad085

Table 2.

Changes in height and BMI SDS in the rhGH-treated group.

Parameter (SDS) N Mean ± SD Min Max
ΔH T1-T0 25 0.6 ± 0.5 −0.3 1.9
ΔH T3-T0 11 1.3 ± 1.0 −0.2 3.4
ΔBMI T1-T0 25 0.0 ± 0.6 −1.1 1.5
ΔBMI T3-T0 11 0.2 ± 1.1 −1.9 1.8

Abbreviations: rhGH, recombinant human growth hormone; BMI, body mass index; SDS, standard deviation score; Min/Max, minimum/maximum; N, number of cases; ΔH T1-T0 and ΔBMI T1-T0, height and BMI difference in SDS after 1 year of therapy; ΔH T3-T0 and ΔBMI T3-T0, height and BMI difference in SDS after 3 years of therapy.